| Oct 21 |
NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B
|
| Oct 21 |
Novo Nordisk: Time To Stay Calm Amid The Recent Plunge (Rating Upgrade)
|
| Oct 21 |
The pill form of Ozempic can reduce the risk of heart attacks and strokes, study says
|
| Oct 21 |
Novo Nordisk semaglutide cut cardio risks by 14% in diabetics: study
|
| Oct 21 |
I'm a pharmacist. Knockoff Ozempic and other weight loss products have serious hidden risks
|
| Oct 21 |
Novo Nordisk: A Diabetes Leader Among Big Pharma, But Still Overvalued
|
| Oct 21 |
Wegovy Maker Novo Nordisk's Oral Diabetes Pill Cuts Heart Attacks, Stroke Events By 14%
|
| Oct 21 |
Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial
|
| Oct 18 |
Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug
|
| Oct 18 |
European Equities Close Mostly Higher in Friday Trading; Novo Nordisk's Catalent Acquisition Faces Roadblock
|
